Literature DB >> 11673400

Dynamic mutations: a decade of unstable expanded repeats in human genetic disease.

R I Richards1.   

Abstract

The term 'dynamic mutation' was introduced to distinguish the unique properties of expanding, unstable DNA repeat sequences from other forms of mutation. The past decade has seen dynamic mutations uncovered as the molecular basis for a growing number of human genetic diseases and for all of the characterized 'rare' chromosomal fragile sites. The common properties of the repeats in different diseases and fragile sites have given insight into this unique form of DNA instability. While the dynamic mutation mechanism explains some unusual genetic characteristics, unexpected findings have raised new questions and challenged some assumptions about the pathways that lead from mutation to disease. This review will address the current understanding of the molecular mechanisms involved in the dynamic mutation process and elaborate on the pathogenic pathways that lead from expanded repeats to the diseases with which they are associated.

Entities:  

Mesh:

Year:  2001        PMID: 11673400     DOI: 10.1093/hmg/10.20.2187

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  28 in total

1.  The guanine-rich fragile X chromosome repeats are reluctant to form tetraplexes.

Authors:  Petr Fojtík; Iva Kejnovská; Michaela Vorlícková
Journal:  Nucleic Acids Res       Date:  2004-01-12       Impact factor: 16.971

2.  Potential for retroposition by old Alu subfamilies.

Authors:  Karla Johanning; Claudina Alemán Stevenson; Oluwatosin O Oyeniran; Yair M Gozal; Astrid M Roy-Engel; Jerzy Jurka; Prescott L Deininger
Journal:  J Mol Evol       Date:  2003-06       Impact factor: 2.395

3.  Chemically induced increases and decreases in the rate of expansion of a CAG*CTG triplet repeat.

Authors:  Mário Gomes-Pereira; Darren G Monckton
Journal:  Nucleic Acids Res       Date:  2004-05-20       Impact factor: 16.971

4.  DNA energy landscapes via calorimetric detection of microstate ensembles of metastable macrostates and triplet repeat diseases.

Authors:  Jens Völker; Horst H Klump; Kenneth J Breslauer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-17       Impact factor: 11.205

Review 5.  Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis.

Authors:  Wenzhi Tan; Piera Pasinelli; Davide Trotti
Journal:  Biochim Biophys Acta       Date:  2014-02-22

6.  Polymerase chain reaction, nuclease digestion, and mass spectrometry based assay for the trinucleotide repeat status of the fragile X mental retardation 1 gene.

Authors:  Eric D Dodds; Flora Tassone; Paul J Hagerman; Carlito B Lebrilla
Journal:  Anal Chem       Date:  2009-07-01       Impact factor: 6.986

7.  Distinct roles for Toll and autophagy pathways in double-stranded RNA toxicity in a Drosophila model of expanded repeat neurodegenerative diseases.

Authors:  Saumya E Samaraweera; Louise V O'Keefe; Gareth R Price; Deon J Venter; Robert I Richards
Journal:  Hum Mol Genet       Date:  2013-03-21       Impact factor: 6.150

8.  Analysis of microsatellites in 13 hemiascomycetous yeast species: mechanisms involved in genome dynamics.

Authors:  Alain Malpertuy; Bernard Dujon; Guy-Franck Richard
Journal:  J Mol Evol       Date:  2003-06       Impact factor: 2.395

9.  Mutations in yeast replication proteins that increase CAG/CTG expansions also increase repeat fragility.

Authors:  Julie L Callahan; Kenneth J Andrews; Virginia A Zakian; Catherine H Freudenreich
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

10.  Expression levels of DNA replication and repair genes predict regional somatic repeat instability in the brain but are not altered by polyglutamine disease protein expression or age.

Authors:  Amanda G Mason; Stephanie Tomé; Jodie P Simard; Randell T Libby; Theodor K Bammler; Richard P Beyer; A Jennifer Morton; Christopher E Pearson; Albert R La Spada
Journal:  Hum Mol Genet       Date:  2013-11-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.